Cannabidiol in Sickle Cell Disease

NCT06930703 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease

Interventions

DRUG: Cannabidiol
DRUG: Placebo

Sponsor

Icahn School of Medicine at Mount Sinai